Global Analysis of MicroRNA Tools and Services Market

News provided by

Nov 21, 2013, 12:06 ET

NEW YORK, Nov. 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Analysis of MicroRNA Tools and Services Market
http://www.reportlinker.com/p01628608/Global-Analysis-of-MicroRNA-Tools-and-Services-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genetically_Modified_Organism,_GMO

Evolving microRNA Market Provides an Opportunity for Vendors of qRT-PCR and Functional Tools

The study covers the analysis and forecasts of MicroRNA tools and services market globally for the period 2009 to 2017. The market is broadly classified into 2 major segments – tools and services. MicroRNA tools market is further segmented into qRT-PCR, microarrays, and functional tools, while services market is further segmented into expression profiling and analysis and phenotypic analysis. The study also covers competitive analysis, product analysis, revenue forecasts, and market shares for the segments covered as part of this research. The base year is 2012 and the forecast period is from 2013 to 2017.

Methodology

The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with the major tool and reagent and service providers for microRNA (or miRNA) market. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various companies within the mass spectrometry market.

The analysis contained in this research service is based on the following:
• Information collected through discussions with market participants and from secondary sources—government, industry associations, companies and other web sites, and other credible sources.
• Public announcements and plans by original equipment manufacturers (OEMs), suppliers, new entrants, and others.
• Frost & Sullivan's published research and market and technology expertise. Forecasts are based on the data and analyses relating to industry challenges, market drivers and restraints, and market trends. If specific revenues or market sizes were unavailable, estimates were derived through consultations with industry experts, augmented by secondary research. Growth trends specific to certain market participants are based on consultations, past growth rates, and technology reviews.

Industry-specific information obtained includes:
• Revenue breakdowns by technology segments and regions specific to miRNA;
• Company revenues, market share estimates, and projected growth rates of various competitors;
• Market information, including customers and regional and technology trends, and;
• Market drivers, restraints, and challenges.

Key Findings

• The total market for miRNA tools was $X million in 2012 and is expected to reach $Xmillion in 2017. The market is expected to grow at a compound annual growth rate (CAGR) of X%.
• Likewise, the market for miRNA services accounted for $X million in 2012 and is expected to reach $Xmillion in 2017. The CAGR for this period is expected to be X%.
• For the miRNA tools market, the United States (US) contributed X%, with Europe positioned at X% and X% from Asia-Pacific (APAC) and Rest of World (RoW). Latin American countries such as Brazil and Mexico are slow and backlogged in relation to miRNA research spectrum.
• Technology segmentation determined that miRNA quantitative real-time polymerase chain reaction (qRT- PCR) remains the most popular segment with a global growth rate of X% during the forecast period. This is closely followed by functional analysis and this segment will tend to gain momentum during the forecast period especially in the US and Europe, projecting a growth rate of X%.

• Within the miRNA services sector, expression arrays segment makes up X% of the market share, leaving the remaining X% to phenotypic screening. The functional analysis segment is expected to catch up post 2015 where Frost & Sullivan predicts rapid utilisation of mimic and inhibitor libraries.
• Lack of infrastructure, personnel, and the requirement for faster turnaround times for funding and grant applications necessitates the need to outsource projects, thereby, opening up larger markets for miRNA service providers.
• The market puts microarray providers and vendors at a risk in the long term during the forecast period. In order to be able to differentiate themselves from the rest of the service providers, there is a trend towards offering miRNA sequencing, microarray, and polymerase chain reaction (PCR) services at competitive prices.
• Market estimates reveal that across the globe, Asia projects the largest market share for microarray application, while the US and European markets have reached their maturity stage where each of the market participants enjoys an equitable share of the revenues, leaving minimal scope for year-on-year growth. The technology will still remain a validating method to cross-reference the data from sequencers and this will keep the market at stagnated revenue each year.
• The existing competitive landscape is dominated by Qiagen, Life Technologies (Thermo Fisher Scientific), Exiqon, Affymetrix, Agilent Technologies, Dharmacon (Thermo Fisher Scientific), and Sigma Aldrich.
• Key companies to watch are Genecopoeia, Nanostrings, Applied Biological Material, and Quanta Biosciences.

Regional Trends: Laboratory consolidation and cost constraint shrink the overall market in Europe. Moreover, an estimated X% of researchers develop their own arrays (home-brew).
• The APAC market gains more popularity due to increased investment from foreign companies in emerging nations such as Japan, China, and India.
• Moreover, sustainability of clinical trials is never a problem as this territory presents a huge patient pool. Local mergers and acquisitions and governmental funding and expansion into complex research will drive the industry forward.
• In the US, the diagnostic field has had an uptake of miRNA research in the past decade, and the pharmaceutical companies are slower with the release of miRNA-based therapeutic products.
• The growth of therapeutic and diagnostic companies in the US will present a large opportunity in the market. At the same time, the US sequestration measures are expected to slow down the market.

Scope and Segmentation

Geographic Coverage: Global
Geographic Segmentation: US, Europe, APAC, and RoW
Europe: Western Europe, Central and Eastern Europe
APAC: Singapore, Japan, Taiwan, India, China, South Korea, Australia, New Zealand, Middle East, Malaysia
RoW: Africa, Latin America, Russia

Market Segmentation:
- Tools: miRNA qRT-PCR, miRNA Microarray, Functional Analysis
- Services: Expression Profiling, Phenotypic Screening

Study period: 2009–2017
Base year: 2012
Forecast period: 2013–2017

Monetary unit: US Dollars

• Revenues for the miRNA tools are obtained from 3 major segments—the miRNA qRT-PCR, miRNA microarray, and functional analysis tools. To maintain the scope of research, home-brew kits and instruments pertaining to sequencing technologies have not been considered for the calculation.
• Revenues from the miRNA services market are computed from the academic laboratories and other commercial laboratories across the globe that use certified technologies from the market leaders to profile miRNAs.

Key Questions This Study Will Answer

What are the key technologies currently used for miRNA expression? Which of the technologies are likely to have growth?
Are the products/services offered currently meeting customer needs, or is there any additional development needed?
Which competitors are competing successfully in their technology segments and why?
How will the structure of the market change over time? Is it ripe for acquisitions?
How supportive are the current regulatory bodies, what impact do they have in various regions?
How does the use of miRNA attribute towards the growth of diagnostic and therapeutic sector?

Table of Contents

1. Executive Summary
• Key Findings
• Scope and Segmentation
• Key Questions This Study will Answer
• CEO's Perspective
• Key Companies to Watch
2. Market Overview
• Market Background
• Future Trends
• Market Segmentation
• Global Market Perspective
3. Competitive Playbook
• New Market Opportunities
• Mergers, Acquisitions, Partnership Assessment
4. Drivers, Restraints, and Trends—Total Tools and Services Market
5. Forecasts and Trends—miRNA Tools Market
• Forecast Assumptions
• Revenue Forecast by Region
• Revenue Forecast by Segment
• Per cent Revenue by Segment
• Revenue Forecast Discussion
6. Forecasts and Trends—miRNA Market
• Per cent Revenue Forecast by Region
• Revenue Forecast by Segment
• Per cent Revenue Forecast by Segment
• Revenue Forecast Discussion

7. Competitive Environment
• Product Analysis
• Top Competitors
• Customer Behaviour
• Product Line Analysis
8. Regional Analysis
9. US Breakdown
• Market Analysis
• Key Findings—US miRNA Tools
• Key Findings—US miRNA Services
• PEST Analysis
10. US miRNA Tools Market
• US Revenue Forecasts and Discussion
11. US miRNA qRT-PCR Market
• Revenue Forecasts
• Market Share Analysis
12. US miRNA Microarray Market
• Revenue Forecasts
• Market Share Analysis
13. US miRNA Functional Analysis Market
• Revenue Forecasts
• Market Share Analysis
14. US miRNA Services Market
• Revenue Forecasts
• Revenue Forecasts by Segment
• Key miRNA Service Providers
15. Europe Breakdown
• Market Analysis
• Key Findings—European miRNA Tools
• Key Findings—European miRNA Services
• PEST Analysis
16. European miRNA Tools Market
• European Revenue Forecasts and Discussion
17. Europe miRNA qRT-PCR Market

• Revenue Forecasts
• Market Share Analysis
18. Europe miRNA Microarray Market
• Revenue Forecasts
• Market Share Analysis
19. Europe miRNA Functional Analysis Market
• Revenue Forecasts
• Market Share Analysis
20. European miRNA Services Market
• Revenue Forecasts
• Revenue Forecasts by Segment
• Key miRNA Service Providers
21. APAC and ROW Breakdown
• Market Analysis
• Key Findings—APAC and RoW miRNA Tools Market
• Key Findings—APAC and RoW miRNA Services Market
• PEST Analysis
22. APAC and ROW miRNA Tools Market
• Revenue Forecasts
• Revenue Forecasts by Segment
• Competitive Positioning
23. APAC and ROW miRNA Services Market
• Revenue Forecasts
• Revenue Forecasts by Segment
• Key Participants miRNA Service Providers
24. Key Companies to Watch
25. Key Companies—Diagnostic and Therapeutic Pipelines
26. The Last word
27. Appendix

List of Exhibits

• Total miRNA Tools and Services Market: Research Methodology, Global, 2012
• miRNA Tools Market: Market Engineering Measurements, Global, 2012
• miRNA Services Market: Market Engineering Measurements, Global, 2012
• Total miRNA Tools and Services Market: Future Market Trends, Global, 2005–2025
• Total miRNA Tools and Services Market: miRNA Profiling Technologies, Global, 2012
• Total miRNA Tools and Services Market: Market Segmentation, Global, 2012
• miRNA Tools Market: Revenue Breakdown by Geographic Region, Global, 2012
• miRNA Services Market: Revenue Breakdown by Geographic Region, Global, 2012
• Total miRNA Tools and Services Market: Market Outlook, Global, 2012 and 2020
• miRNA Tools Market: Technology Lifecycle Analysis, Global, 2012
• Total miRNA Tools and Services Market: Game-changing Strategies, Global, 2012
• Total miRNA Tools and Services Market: Market Outlook, Global, 2006–2013
• Total miRNA Tools and Services Market: Key Market Drivers, Global, 2013–2017
• Total miRNA Tools and Services Market: Key Market Restraints, Global, 2013–2017
• Total miRNA Tools and Services Market: Impact of Top 9 Trends, Global, 2012
• miRNA Tools Market: Market Engineering Measurements, Global, 2012
• miRNA Tools Market: Revenue Forecast by Region, Global, 2009–2017
• miRNA Tools Market: Revenue Forecast by Region, Global, 2009–2017
• miRNA Tools Market: Revenue Forecast by Segment, Global, 2009–2017
• miRNA Tools Market: Per cent Revenue Forecast by Segment, Global, 2009–2017
• miRNA Services Market: Market Engineering Measurements, Global, 2012
• Services Market: Per cent Revenue Forecast by Region, Global, 2009–2017
• miRNA Services Market: Revenue Forecast by Region, Global, 2009–2017
• miRNA Services Market: Revenue Forecast by Segment, Global, 2009–2017
• miRNA Services Market: Per cent Revenue Forecast by Segment, Global, 2009–2017
• miRNA Services Market: Expression Profiling and Analysis Services Outlook Global, 2012 and 2017
• miRNA Services Market: Phenotypic Screening Services Outlook, 2012 and 2017
• miRNA Tools Market: Procurement Process, Global, 2012
• Total miRNA Tools and Services Market: Product Analysis of Tier I, Global, 2012
• Total miRNA Tools and Services Market: SWOT Analysis, Global, 2012
• Total miRNA Tools and Services Market: Customer Behaviour, Global, 2012
• Total miRNA Tools and Services Market: Product Line Analysis, Global, 2012
• miRNA Tools Market: Per cent Sales Breakdown, US, 2012
• miRNA Services Market: Per cent Sales Breakdown, US, 2012
• Total miRNA Tools and Services Market: PEST Analysis, US, 2012
• miRNA Tools Market: US, 2012
• miRNA Tools Market: Revenue Forecast, US, 2009–2017
• miRNA qRT-PCR Segment: Revenue Forecast, US, 2009–2017
• Total qRT-PCR Reagents Market: Per cent of miRNA qRT-PCR Segment , US, 2012
• miRNA qRT-PCR Segment: Per cent Sales Breakdown, US, 2012
• miRNA qRT-PCR Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
• miRNA Microarray Segment: Revenue Forecast, US, 2009–2017

• miRNA Microarray Segment: Per cent Sales Breakdown, US, 2012
• miRNA Microarray Segment: Company Market Share Analysis of Top 3 Participants, US, 2012
• miRNA Functional Analysis Segment: Revenue Forecast, US, 2009–2017
• miRNA Functional Analysis Segment: Per cent Sales Breakdown, US, 2012
• miRNA Functional Analysis Segment: Company Market Share Analysis of Top 5 Participants, US, 2012
• miRNA Services Market: US, 2012
• miRNA Services Market: Revenue Forecast, US, 2009–2017
• miRNA Services Market: Revenue Forecast by Segment, US, 2009–2017
• miRNA Services Market: Key Service Providers, US, 2012
• miRNA Tools Market: Per cent Sales Breakdown, Europe, 2012
• miRNA Services Market: Per cent Sales Breakdown, Europe, 2012
• Total miRNA Tools and Services Market: PEST Analysis, Europe, 2012
• miRNA Tools Market: Europe, 2012
• miRNA Tools Market: Revenue Forecast, Europe, 2009–2017
• miRNA qRT-PCR Segment: Revenue Forecast, Europe, 2009–2017
• Total qRT-PCR Reagents Market: Per cent of miRNA qRT-PCR segment, Europe, 2012
• miRNA qRT-PCR Segment: Per cent Sales Breakdown, Europe, 2012
• miRNA qRT-PCR Segment: Company Market Share Analysis of Top 3 Participants, Europe, 2012
• miRNA Microarray Segment: Revenue Forecast, Europe, 2009–2017
• miRNA Microarray Segment: Per cent Sales Breakdown, Europe, 2012
• miRNA Microarray Segment: Company Market Share Analysis of Top 3 Participants, Europe, 2012
• miRNA Functional Analysis Segment: Revenue Forecast, Europe, 2009–2017
• miRNA Functional Analysis Segment: Per cent Sales Breakdown, Europe, 2012
• miRNA Functional Analysis Segment: Company Market Share Analysis of Top 5 Participants, Europe, 2012
• miRNA Services Market: Europe, 2012
• miRNA Services Market: Revenue Forecast, Europe, 2009–2017
• miRNA Services Market: Revenue Forecast by Segment, Europe, 2009–2017

• miRNA Services Market: Per cent of miRNA Service Providers by Region, Europe, 2012
• miRNA Services Market: Key Service Providers, Europe, 2012
• miRNA Tools Market: Per cent Sales Breakdown, APAC and RoW, 2012
• miRNA Services Market: Per cent Sales Breakdown, APAC and RoW
• Total miRNA Tools and Services Market: PEST Analysis, APAC and RoW, 2012
• miRNA Tools Market: APAC and RoW, 2012
• miRNA Tools Market: Revenue Forecast, APAC and RoW, 2009–2017
• miRNA Tools Market: Revenue Forecast by Segment, APAC and RoW, 2009–2017
• Total miRNA Tools and Services Market: Competitive Positioning of Countries, APAC, 2012
• miRNA Services Market: APAC and RoW, 2012
• miRNA Services Market: Revenue Forecast, APAC and RoW, 2009–2017
• miRNA Services Market: Revenue Forecast by Segment, APAC and RoW, 2009–2017
• miRNA Services Market: Key Service Providers, APAC and RoW, 2012
• miRNA Tools and Services Market: Nanostring Technologies Company Assessment, Global, 2012
• miRNA Tools and Services Market: Genecopoeia Company Assessment, Global, 2012
• miRNA Tools and Services Market: Quanta Biosciences Company Assessment, Global, 2012
• miRNA Tools and Services Market: Applied Biological Material Company Assessment, Global, 2012
• Total miRNA Tools and Services Market: Distribution Based on Particular Type of Disease Indication, US, 2012
• Total miRNA Tools and Services Market: miRNA-related Patent Distribution, US, 2012
• Global miRNA Tools and Services: Uptake of Technology, Global, 2012